Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: PACT COALITION · Firm: FARRAGUT PARTNERS LLP
Issues related to HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act
Client: PACT COALITION · Firm: FARRAGUT PARTNERS LLP
Issues related to HR 4299
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COMCAST CORPORATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · 3A
Privacy issues relating to the gathering, retention, and use of online information.
Spectrum Reform. Cyber security. Program carriage. Rural Broadband Infrastructure. Privacy Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| ALTRIA CLIENT SERVICES LLC |
| 2 |
| 2026 |
| AT&T SERVICES, INC. | 2 | 2026 |
| CARDIAC PET ALLIANCE | 2 | 2026 |
| DTE ENERGY | 2 | 2026 |
| NATIONAL CABLE AND TELECOMMUNICATIONS ASSOCIATION | 2 | 2026 |
| ONEONCOLOGY INC. | 2 | 2026 |
| SILFAB SOLAR | 2 | 2026 |
| TECHNET THE VOICE OF INNOVATION ECONOMY | 2 | 2026 |
| ACTIO HEALTH, INC | 1 | 2026 |
| AGILENT TECHNOLOGIES, INC. | 1 | 2026 |
| AGILIX HEALTH | 1 | 2026 |
| COMMUNITY ONCOLOGY ALLIANCE | 1 | 2026 |
| VERASTEM ONCOLOGY | 1 | 2026 |
Protecting Patient Access to Cancer and Complex Therapies Act
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: FARRAGUT PARTNERS LLP
Issues relating to HR 4299, Protecting Patients' Access to Cancer and Complex Therapies Act, and general healthcare
Protecting Patient Access to Cancer and Complex Therapies Act
Client: SIEMENS HEALTHINEERS · Firm: FARRAGUT PARTNERS LLP
Issues related to HR6197 and HR4299 (patient access)
Issues related to physician reimbursement, AI policy, radiation oncology cuts and HR 6197 Health Tech Investment Act
Issues related to physician reimbursement, AI policy, radiation oncology cuts and HR 6197 Health Tech Investment Act
Issues related to HR6197 and HR4299 (patient access)
To designate the facility of the United States Postal Service located at 2600 Michigan Avenue in Kissimmee, Florida, as the "Robert Guevara Post Office Building".
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: FARRAGUT PARTNERS LLP
Issues relating to HR 7299 and other heath issues.
To designate the facility of the United States Postal Service located at 2600 Michigan Avenue in Kissimmee, Florida, as the "Robert Guevara Post Office Building".
Client: TAKEDA PHARMACEUTICALS AMERICA INC · Firm: FARRAGUT PARTNERS LLP
Issues relating to HR 7299 and other heath issues.
2026 · third_quarter · Q3
Issues related to cardiac PET scans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SILFAB SOLAR via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to Section 232 polysilicon tariffs
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, White House Office
PACT COALITION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to HR 4299
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CARDIOVASCULAR ASSOCIATES OF AMERICA via FARRAGUT PARTNERS LLP
2026 · third_quarter · 3T
Issues related to cardiac PET scans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to physician reimbursement, AI policy, radiation oncology cuts and HR 6197 Health Tech Investment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH SUPPLY US via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to domestic manufacturing and reindustrialization
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ACTIO HEALTH, INC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to medication adherence and population health issues related to the expansion of the Actio Health patient engagement ecosystem within VA facilities
Issues related to medication adherence and population health issues related to the expansion of the Actio Health patient engagement ecosystem within VA facilities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)
TECHNET THE VOICE OF INNOVATION ECONOMY via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues related to federal privacy legislation and other.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DTE ENERGY via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
general representation related to the power grid, energy efficiency and climate change
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONEONCOLOGY LLC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation.
Issues related to pharmacy benefit managers.
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation
AT&T SERVICES INC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Copyright, communications and consumer protection
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Net Neutrality. Spectrum Reform. Cyber security. Program carriage. Rural Broadband Infrastructure. Privacy Issues
Privacy issues relating to the gathering, retention, and use of online information.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMMUNITY ONCOLOGY ALLIANCE via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Legislation regarding the 340B Drug discount program. Issues related to pharmacy benefit managers. Drug Pricing legislation. 21st Century Cures 2.0
Issues related to pharmacy benefit managers. TACT Act
Issues pertaining to Medicare reimbursement. Legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. CMMI demonstration (OCM/OCF)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL CABLE AND TELECOMMUNICATIONS ASSOCIATION via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Privacy and Behavioral Advertising issues relating to the gathering, retention, and use of online information. Program access, Net neutrality, spectrum reform and reallocation, broadband deployment issues including use of stimulus finds for rural broadband deployment and adoption and broadband conduit legislation. National Broadband Plan issues relating to competition and innovation in navigation devices
Privacy and Behavioral Advertising issues relating to the gathering, retention, and use of online information. Program access, Net neutrality, spectrum reform and reallocation, broadband deployment issues including use of stimulus finds for rural broadband deployment and adoption and broadband conduit legislation. National Broadband Plan issues relating to competition and innovation in navigation devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES LLC via FARRAGUT PARTNERS LLP
2026 · third_quarter · Q3
Implementation of Family Smoking Protection and Tobacco Control Act of 2009 and FDA Tobacco Product Deeming proposed Rule. Legislation pertaining to flavor bans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CARDIAC PET ALLIANCE via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues related to cardiac PET scans
VERASTEM ONCOLOGY via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues related to FDA approval of oncology drugs and drug pricing
AGILIX HEALTH via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues relating to nutritional and dietary policies
SILFAB SOLAR via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues related to Section 232 polysilicon tariffs
AGILENT TECHNOLOGIES, INC. via FARRAGUT PARTNERS LLP
2026 · third_quarter · RR
Issues related to healthcare tariffs, supply chain, and taxes
Issues related to healthcare tariffs, supply chain, and taxes
Issues related to healthcare tariffs, supply chain, and taxes
AT&T SERVICES INC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Copyright, communications and consumer protection
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA INC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues relating to HR 7299 and other heath issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACT COALITION via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to HR 4299
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CARDIOVASCULAR ASSOCIATES OF AMERICA via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to cardiac PET scans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS HEALTHINEERS via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to physician reimbursement, AI policy, radiation oncology cuts and HR 6197 Health Tech Investment Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH SUPPLY US via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to domestic manufacturing and reindustrialization
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TECHNET THE VOICE OF INNOVATION ECONOMY via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues related to federal privacy legislation and other.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DTE ENERGY via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
general representation related to the power grid, energy efficiency and climate change
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ONEONCOLOGY LLC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation
Issues pertaining to Medicare reimbursement. Issues pertaining to drug shortages, legislation regarding the 340B Drug discount program. Issues pertaining to sequestration; Issues related to pharmacy benefit managers. Drug Pricing legislation. Monitoring CMMI Demonstration Projects. CON regulations. CARES implementation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMCAST CORPORATION via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Net Neutrality. Spectrum Reform. Cyber security. Program carriage. Rural Broadband Infrastructure. Privacy Issues
Privacy issues relating to the gathering, retention, and use of online information.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CABLE AND TELECOMMUNICATIONS ASSOCIATION via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Privacy and Behavioral Advertising issues relating to the gathering, retention, and use of online information. Program access, Net neutrality, spectrum reform and reallocation, broadband deployment issues including use of stimulus finds for rural broadband deployment and adoption and broadband conduit legislation. National Broadband Plan issues relating to competition and innovation in navigation devices
Privacy and Behavioral Advertising issues relating to the gathering, retention, and use of online information. Program access, Net neutrality, spectrum reform and reallocation, broadband deployment issues including use of stimulus finds for rural broadband deployment and adoption and broadband conduit legislation. National Broadband Plan issues relating to competition and innovation in navigation devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES LLC via FARRAGUT PARTNERS LLP
2026 · second_quarter · Q2
Implementation of Family Smoking Protection and Tobacco Control Act of 2009 and FDA Tobacco Product Deeming proposed Rule. Legislation pertaining to flavor bans.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA INC via FARRAGUT PARTNERS LLP
2026 · first_quarter · Q1
Issues relating to HR 7299 and other heath issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TAKEDA PHARMACEUTICALS AMERICA INC via FARRAGUT PARTNERS LLP
2026 · first_quarter · RR
Issues relating to HR 4299, Protecting Patients' Access to Cancer and Complex Therapies Act, and general healthcare
SIEMENS HEALTHINEERS via FARRAGUT PARTNERS LLP
2026 · second_quarter · RR
Issues related to HR6197 and HR4299 (patient access)
CARDIOVASCULAR ASSOCIATES OF AMERICA via FARRAGUT PARTNERS LLP
2026 · second_quarter · RR
Issues related to cardiac PET scans
PACT COALITION via FARRAGUT PARTNERS LLP
2026 · second_quarter · RR
Issues related to patient access
HEALTH SUPPLY US via FARRAGUT PARTNERS LLP
2026 · second_quarter · RR
Issues related to domestic manufacturing and reindustrialization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE